Joanne Blum
Medical Oncology · Dallas, TXNPI 1285676411
Payments from drug & device makers
Across 192 payments — averaging $10,407 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$1.2M
- Pfizer$269K
- Novartis$174K
- Medivation LLC.$150K
- Sanofi US Services Inc.$104K
- Eli Lilly$55K
- plus $41K from 9 others
Across 69 payments — averaging $1101.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$75K
- Eli Lilly$1K
What the payments were for
- Consulting fees$19,79827%
- Speaking & faculty fees$30,22042%
- Travel & lodging$19,89628%
- Food & beverage$7731%
- Education$120%
- Other$1,6152%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 2 | $1,204,010 |
| Pfizer | 72 | $269,431 |
| Novartis | 22 | $174,299 |
| Medivation LLC. | 14 | $150,049 |
| Sanofi US Services Inc. | 25 | $104,464 |
| Eli Lilly | 9 | $55,378 |
| AstraZeneca | 7 | $21,570 |
| Daiichi Sankyo Inc. | 9 | $7,937 |
| Puma Biotechnology, Inc. | 5 | $3,618 |
| Amgen | 8 | $3,385 |
| Athenex Pharmaceutical Division, LLC | 5 | $1,850 |
| Gilead | 2 | $1,012 |
| Immunomedics, Inc. | 1 | $1,000 |
| AbbVie | 10 | $170 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IBRANCE$21,396
- TALZENNA$8,740
- Enhertu$7,679
- Nerlynx$3,560
- XGEVA$3,283
- Oral Paclitaxel$1,500
- Encequidar$1,500
- Trodelvy$1,000
How this compares
$1,998,194 in reported general payments places this provider in the 75th percentile of 495 medical oncology providers in Texas.
Other medical oncology in Dallas
- Sawsan RashdanDallas$29.9M
- David GerberDallas$22.8M
- Joyce O'ShaughnessyDallas$20.8M
- Moshe LevyDallas$19.7M
- Minal BarveDallas$16.7M
- Andrew PaulsonDallas$11.5M
- Hans HammersDallas$11.4M
- James StraussDallas$9.1M
- Larry AndersonDallas$8.7M
- Heather McArthurDallas$7.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.